跳至主要内容
临床试验/ISRCTN12196183
ISRCTN12196183已完成4 期

The effects of sodium valproate and oxcarbazepine on semen, sex hormones and sexual function in young male patients with epilepsy

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital0 个研究点目标入组 77 人开始时间: 2020年4月26日最近更新:
适应症
相关药物

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Male

入选标准

  • 1. Patients with simple partial seizures, complex partial seizures or secondarily generalized seizures
  • 2. Healthy young male volunteers (control group)

排除标准

  • 1. Use of hormones, antidepressants, or drugs to improve sexual function
  • 2. Liver and kidney dysfunction, thyroid disease, diabetes, infectious diseases, varicocele, cryptorchidism, history of testicular surgery, Klinefelter syndrome, or urinary system diseases
  • 3. Long-term alcoholism, smoking, or exposure to toxic substances
  • 4. Mental illness, intracranial occupying lesions, brain injury, or progressive degeneration of the nervous system
  • 5. Inability to cooperate or refusal to participate in the study
  • Individual participation in the study was terminated if any of the following conditions were met:
  • 1. Patients experienced adverse drug reactions after taking the medications and needed to discontinue the drug
  • 2. Patients failed to achieve an ideal treatment effect (i.e., the reduction in the frequency of epileptic seizures is less than 75% after three months of treatment), and other AEDs needed to be substituted or added
  • 3. Patients or volunteers took medications or suffered from diseases that might affect the results during the study
  • 4. Participants withdrew from the study for personal reasons

研究者

相似试验